Analysis of Genetic Variants Associated with Levels of Immune Modulating Proteins for Impact on Alzheimer’s Disease Risk Reveal a Potential Role for SIGLEC14
Genome-wide association studies (GWAS) have identified immune-related genes as risk factors for Alzheimer’s disease (AD), including <i>TREM2</i> and <i>CD33</i>, frequently passing a stringent false-discovery rate. These genes either encode or signal through immunomodulatory...
Main Authors: | Benjamin C. Shaw, Yuriko Katsumata, James F. Simpson, David W. Fardo, Steven Estus |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/12/7/1008 |
Similar Items
-
Siglecs in Brain Function and Neurological Disorders
by: Shoib Sarwar Siddiqui, et al.
Published: (2019-09-01) -
Phosphoproteomics identifies microglial Siglec‐F inflammatory response during neurodegeneration
by: Nader Morshed, et al.
Published: (2020-12-01) -
Glycobiology of Eosinophilic Inflammation: Contributions of Siglecs, Glycans, and Other Glycan-Binding Proteins
by: Jeremy A. O’Sullivan, et al.
Published: (2017-08-01) -
Characterization of Sialic Acid-Binding Immunoglobulin-Type Lectins in Fish Reveals Teleost-Specific Structures and Expression Patterns
by: Kim F. Bornhöfft, et al.
Published: (2020-03-01) -
The plasma biomarker soluble SIGLEC-1 is associated with the type I interferon transcriptional signature, ethnic background and renal disease in systemic lupus erythematosus
by: João J. Oliveira, et al.
Published: (2018-07-01)